Resources

Type of publications
Regions
Diseases

5192 results found

2024 ∙ Whitworth, H. S. Mounier-Jack, S. Choi, E. M. Gallagher, K. E. Howard, N. Kelly, H. Mbwanji, G. Kreimer, A. R. Basu, P. Barnabas, R. Drolet, M. Brisson, M. Watson-Jones, D.

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of evidence from clinical trials

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Jain, H. Odat, R. M. Hussein, A. M. Dey, D. Ahmed, M. Jain, J. Goyal, A. Ratnani, T. Idrees, M. Prajjwal, P. Passey, S. Yadav, R.

Efficacy and outcomes of BCG re-vaccination in COVID-19: a systematic review, meta-analysis, and meta-regression of randomized controlled trials

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Rayner, D. G. Nunes, J. T. Gou, D. Chu, A. W. L. Dai, S. C. Sheikh, A. Meng, D. Orchanian-Cheff, A. Oss, S. Rotstein, C. Aleksova, N. Foroutan, F.

Efficacy and safety of COVID-19 vaccination in solid organ transplant recipients: A systematic review and network meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2024 ∙ Choi, S. H. Yu, S. Y. Kim, J. Choi, M. Choi, Y. Y. Choi, J. H. Yun, K. W. Choe, Y. J.

Efficacy and Safety of COVID-19 Vaccines in Adolescents: Systematic Review of Randomized Controlled Studies and Observational Studies

  • Adolescents
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Qiu, J. Zhang, S. Feng, Y. Su, X. Cai, J. Chen, S. Liu, J. Huang, S. Huang, H. Zhu, S. Wen, H. Li, J. Yan, H. Diao, Z. Liang, X. Zeng, F.

Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses

  • All age groups
  • Hepatitis B
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Zeng, B. Liu, X. Yang, Q. Wang, J. Ren, Q. Sun, F.

Efficacy and safety of vaccines to prevent respiratory syncytial virus infection in infants and older adults: A systematic review and meta-analysis

  • Adults
  • Older adults
  • Pregnant women
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Cheng, M. Q. Weng, Z. Y. Li, R. Song, G.

Efficacy of adjuvant-associated COVID-19 vaccines against SARS-CoV-2 variants of concern in randomized controlled trials: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Moreira, A. C. Ribeiro, A. B. Oliveira, I. Sa, M. Lameirao, C. Marques, P.

Efficacy of anti-RSV vaccination in preventing respiratory syncytial virus disease and severe illness in older adults: a systematic review of randomized controlled trials

  • Adults
  • Older adults
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Kanan, M. Alotaibi, N. Munif, M. Alghumuy, A. Alsayed, M. Almanjumi, S. Alnemari, J. Altwairqi, W. Marwai, A. Alfaifi, K. Alkharisi, R. Madkhali, H. Alotaibi, S. Asiri, S.

Efficacy of bivalent, quadrivalent and nonavalent vaccines against human papillomavirus and cervical intraepithelial lesions: A systematic review

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Das Barshan, A. Matsumoto-Takahashi, E. L. A.

Efficacy of COVID-19 Vaccines in Patients with Hematological Malignancy Compared to Healthy Controls: A Systematic Review and Meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...